Praxis Precision Medicines, Inc(NASDAQ:PRAX) 
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in...
Website: http://www.praxismedicines.com
Founded: 2015
Full Time Employees: 50
CEO: Marcio Souza
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 32.38
H 34.18
L 31.44
C 32.65
V 413,178
10EMA 32.65
20EMA 32.65
60EMA 32.65
120EMA 32.65
250EMA 32.65